Showing results (341-350 of 391) with videos related to

Sort By:
Pageof 40
NPJ Breast Cancer|April 17, 2021
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohortThomas Grinda, Natacha Joyon, Amélie Lusque, et al.
International Journal of Cancer|March 13, 2019
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancerFlorence Coussy, Leanne de Koning, Marion Lavigne, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2023
Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancerKaren Van Baelen, Ha-Linh Nguyen, Anne-Sophie Hamy-Petit, et al.
Annales De Pathologie|April 20, 2004
[HER2 gene amplification assay: is CISH an alternative to FISH?]Yves Denoux, Laurent Arnould, Maryse Fiche, et al.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
JAMA Ophthalmology|June 18, 2025
Uveal Melanoma and the Lynch Syndrome Tumor SpectrumAnaïs Le Ven, Marie-Charlotte Villy, André Bortolini Silveira, et al.
Histopathology|January 16, 2016
Phyllodes tumours of the breast: a consensus reviewBenjamin Y Tan, Geza Acs, Sophia K Apple, et al.
Nature Communications|March 14, 2026
Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressivenessMichel Kahi, Abigail Mazzu, Ludovic Batistic, et al.
Annales De Pathologie|November 9, 2010
[Update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]Frédérique Penault-Llorca, Anne Vincent-Salomon, Jean-Pierre Bellocq, et al.
Nature Medicine|March 6, 2023
Evolution of synchronous female bilateral breast cancers and response to treatmentAnne-Sophie Hamy, Judith Abécassis, Keltouma Driouch, et al.
Pageof 40